ClinicalTrials.gg
Not yet recruitingNCT07803458BRAVEUpdated Sep 3, 2026

Attention-based Binocular Training for Impaired Stereopsis (BRAVE)

An interventional study of Attention-Guided Dichoptic Visual Search Training and Zero-Disparity Dichoptic Visual Search Task in Amblyopia, Strabismus and Anisometropia, sponsored by Centre for Eye and Vision Research. Not yet recruiting at 2 sites in Hong Kong. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Centre for Eye and Vision Research · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

This study evaluates a novel attention-based binocular visual search training paradigm designed to improve stereopsis (stereo vision) in individuals with impaired binocular vision. Disruptions in balanced binocular input, such as from strabismus or anisometropia, often lead to deficient stereo vision, causing daily visuomotor limitations. While traditional therapies focus on monocular acuity, they frequently fail to restore stereopsis, especially in adults. The investigators propose a unique dichoptic visual search training method that embeds binocular disparity inside an attention-demanding task, encouraging cooperative binocular integration. Participants aged 18-39 with impaired stereopsis will be randomly assigned in a 1:1 ratio to either the active training group (disparity-embeded task) or the active control group (identical task with zero disparity). Both groups complete 5 training sessions over 5-6 weeks. Assessments will occur at baseline, immediately post-training, and at a 12-week follow-up. The primary objective is to determine if the active training group shows significantly greater improvements in local stereoacuity compared to the control group.

02

Conditions studied

  • Amblyopia
  • Strabismus
  • Anisometropia
  • Binocular Vision Abnormalities
  • Binocular Vision Disorder

Keywords

  • Stereopsis
  • Depth Perception
  • Visual Search
  • Visual Attention
  • Dichoptic Training
03

In context

Amblyopia

189 studies on the registry are indexed under Amblyopia; 41 are open to participants now.

This study's planned enrollment of 56 is close to the median of 60 across 137 interventional studies indexed under Amblyopia.

Browse Amblyopia studies →

Lead sponsor

Centre for Eye and Vision Research is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-39 years (inclusive).
  • Deficient or anomalous stereoscopic vision with a stereoacuity >= 70 sec arc or unmeasurable stereoacuity.
  • Best corrected visual acuity (BCVA) of \< 0.80 logMAR in both eyes, with at least one eye having a visual acuity of \<= 0.1 logMAR (uncorrected or corrected-to-normal with glasses or contact lenses).
  • Normal colour vision.
  • Good general health.

Exclusion criteria

Exclusion Criteria:

  • Previous history of ocular surgery (except for refractive correction surgery, where appropriate).
  • Pre-existing ocular conditions or medications that affect vision or visual function.
  • Pre-existing conditions or medications that affect neuropsychological function.
  • Presence of strabismus over 10 prism diopters at distance in current refractive correction measured by simultaneous prism and cover test, or large eccentric fixation.
  • Previous history of experiencing double vision (diplopia).
  • Identified at risk of developing diplopia due to binocular state and/or poor binocular control.
  • Inability to comprehend psychophysical test instructions given and/or consent for themselves.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Active Training Group

    Participants complete a dichoptic visual search task where the search target is uniquely paired with crossed binocular disparity under balanced interocular contrast. The training consists of 5 sessions (5 blocks of 192 trials per session) over 5-6 weeks with adaptive disparity adjustment.

    Behavioral: Attention-Guided Dichoptic Visual Search Training

  • Active comparator
    Active Control Group

    Participants perform an identical computer-based dichoptic visual search task with the same geometric stimuli, trial structure (5 blocks of 192 trials per session), and interocular contrast balancing, but with zero binocular disparity.

    Behavioral: Zero-Disparity Dichoptic Visual Search Task

Interventions

  • BehavioralAttention-Guided Dichoptic Visual Search Training

    A computer-based dichoptic training paradigm in which visual stimuli are presented separately to each eye under balanced interocular contrast . Participants search for conjunction-defined targets across 5 sessions (5 blocks of 192 trials per session). The target stimulus is uniquely paired with crossed binocular disparity to provide depth-based attentional guidance, with target disparity adaptively reduced based on search performance.

  • BehavioralZero-Disparity Dichoptic Visual Search Task

    An active control dichoptic task identical in visual stimuli, trial structure (5 sessions; 5 blocks of 192 trials per session), and interocular contrast balancing to the training arm, but presented with zero binocular disparity (all stimuli appear in the same depth plane without depth cues).

06

What researchers measure

Primary outcomes

  1. Change in Local Stereoacuity

    Measured using the Randot Stereotest - Circles test (graded disparities from 400 to 20 arcsec, 10 levels) under standardized lighting at 40 cm. The score is recorded as the finest disparity correctly identified (in log arcseconds). Nil stereopsis is assigned 3000 arcsec (3.477 log arcsec). The primary metric is the between-group difference in the change score.

    Time frame: Baseline (T0) and Immediately Post-Training (T1, within 7 days after Session 5, approximately 5-6 weeks from baseline).

Secondary outcomes

  1. Retention of Local Stereoacuity Gains

    Measured using the Randot Stereotest - Circles test under crossed disparity (log10 arcsec; nil stereopsis assigned 3000 arcsec) to evaluate long-term maintenance of training effects

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  2. Change in Uncrossed Local Stereoacuity

    Measured using the Randot Stereotest - Circles test with the test booklet rotated 180 degrees (log10 arcsec; nil stereopsis assigned 3000 arcsec).

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  3. Change in Global Stereoacuity

    Measured with the Randot Preschool Stereotest (random-dot stereograms, 800 to 40 arcsec, 6 levels) under both crossed and uncrossed disparity conditions (log10 arcsec; nil stereopsis assigned 3000 arcsec).

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  4. Change in Laboratory-Based Stereoacuity Threshold

    Psychophysical stereoacuity threshold (75% threshold in log10 arcsec) measured using a 4-alternative forced-choice staircase ring test administered dichoptically.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  5. Change in Best-Corrected Visual Acuity (BCVA)

    Monocular (affected/dominant eyes) and binocular distance visual acuity measured using an electronic ETDRS logMAR chart at 4 meters (recorded in logMAR units).

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  6. Change in Interocular Suppression Status

    Binocular status classified into categorical states (fusion, suppression, or diplopia) using the Worth 4-dot test at near (40 cm) and distance (3 m).

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  7. Change in Interocular Suppression Strength (Contrast Balance Ratio)

    Effective suppression depth quantified by the interocular contrast ratio at the perceptual balance point measured via a dichoptic letter-polarity task.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  8. Change in Visual Evoked Potentials (VEPs)

    Peak latencies (ms) and amplitudes (μV) of the transient pattern-reversal VEP N75-P100-N135 complex across high-contrast and isoluminant red-green conditions, alongside harmonic amplitudes/phases (2F, 4F) from steady-state VEPs, recorded via a 64-channel EEG system.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  9. Change in Electrophysiological Marker of Attentional Selection (N2pc Component)

    Mean amplitude (μV) of the posterior contralateral-minus-ipsilateral difference wave (N2pc) extracted across predefined parieto-occipital electrodes (P7, PO7, P8, PO8) during a modified spatial cueing task.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  10. Change in Behavioral Selective Attention

    Spatial cueing effects on mean reaction time (ms) and response accuracy (%) derived from the modified spatial cueing task.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  11. Change in Visual Search Efficiency

    Visual search slope (reaction time as a function of set size, in ms/item) measured from a 192-trial zero-disparity dichoptic visual search task.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  12. Change in Visuomotor Coordination Completion Time and Kinematic Parameters

    Visuomotor dexterity and kinematic performance are assessed using the Grooved Pegboard Test separately for dominant and non-dominant hands. Hand movements during the task are video recorded for detailed kinematic tracking. The primary quantitative metric for this outcome is the total completion time (in seconds) required to successfully place all 25 grooved pegs (shorter duration indicates better motor speed and coordination). Secondary kinematic metrics extracted from video analyses include mean peg-insertion duration (seconds), inter-peg temporal variability across the 25 trials (coefficient of variation, CV), and total drop/error counts.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

  13. Change in Quality of Life Scores

    Domain scores assessed via the World Health Organization Quality of Life Instrument-Short Form (WHO QoL-BREF) and the Amblyopia and Strabismus Questionnaire (A\&SQ). Higher scores indicate superior functional visual ability and quality of life. For both questionnaires, domain and composite scores are linearly transformed to a standardized 0 to 100 scale, where higher scores represent superior functional visual ability, fewer daily limitations, and better overall quality of life.

    Time frame: Baseline (T0), Immediately Post-Training (T1), and 12-Week Follow-Up (T2).

07

Study locations

2 sites
  • Centre for Eye and Vision Research Limited
    Hong Kong, Hong Kong SAR HKG, Hong Kong
    • Benjamin Thompson, PhD · Contactben.thompson@cevr.hk · +852-31699631
    • Tingni Li, PhD · Contacttingni.li@cevr.hk · +852-31699631
    • Benjamin Thompson, PhD · Principal investigator
    • Tingni Li, PhD · Sub investigator
    • Krista Kelly, PhD · Sub investigator
    • Lisa Christian, PhD · Sub investigator
    • Xiaofei Hu, PhD · Sub investigator
    • Ken WS Tan, PhD · Sub investigator
    • Yu Yang · Sub investigator
  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong SAR HKG, Hong Kong
    • Jeffrey TW Leung, PhD · Contactjeffrey.tw.leung@polyu.edu.hk · +852-64080394
    • Jeffrey TW Leung, PhD · Principal investigator
    • Allen MY Cheong, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized data will be shared on request.

Supporting information: Study protocol, Statistical analysis plan

Time frame: After publication of study results for an indefinite period.

Access criteria: Upon reasonable request and approved by the study principal investigator.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07803458
Lead sponsor
Centre for Eye and Vision Research
Collaborators
The Hong Kong Polytechnic University, University of Waterloo
Responsible party
Sponsor
First posted
Sep 3, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Mar 30, 2029 (estimated)
Last update
Sep 3, 2026

Study contacts

Jeffrey TW Leung, PhD
Contact
jeffrey.tw.leung@polyu.edu.hk
+852-64080394
Benjamin Thompson, PhD
Contact
ben.thompson@cevr.hk
+852-31699631

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion